logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12083141 B1

PDFFull Text
Date of Patent:
Sep. 10, 2024

Filed:

Mar. 12, 2020

Treatment of hyperglycemia with solute carrier family 39 member 5 (slc39a5) inhibitors

Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Harikiran Nistala, Tarrytown, NY (US);

Cristopher Van Hout, Tarrytown, NY (US);

Lyndon Mitnaul, Tarrytown, NY (US);

Anthony Marcketta, Tarrytown, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorney:

Armstrong Teasdale LLP

Primary Examiner:

Celine X Qian

Assistant Examiner:

Catherine Konopka

Int. Cl.
CPC ...
A61K 31/7105 (2006.01); A61K 33/30 (2006.01); C07K 14/435 (2006.01); C12Q 1/6876 (2018.01); C12Q 1/6897 (2018.01); G01N 33/66 (2006.01); G01N 33/68 (2006.01); G01N 33/74 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7105 (2013.01); A61K 33/30 (2013.01); C07K 14/435 (2013.01); C12Q 1/6876 (2013.01); C12Q 1/6897 (2013.01); G01N 33/66 (2013.01); G01N 33/6803 (2013.01); G01N 33/74 (2013.01); C12Q 2600/156 (2013.01); G01N 2333/62 (2013.01); G01N 2400/00 (2013.01);
Abstract

The present disclosure provides methods of treating subjects having increased serum glucose level and/or hyperglycemia, methods of identifying subjects having an increased risk of developing increased serum glucose level and/or hyperglycemia, and methods of detecting human Solute Carrier Family 39 Member 5 variant nucleic acid molecules and variant polypeptides.

Find Patent Forward Citations

Nistala, Harikiran. (2024). Treatment of hyperglycemia with solute carrier family 39 member 5 (slc39a5) inhibitors (U.S. Patent No. 12083141). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12083141

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…